Literature DB >> 10732837

Mucoid impaction caused by monokaryotic mycelium of Schizophyllum commune in association with bronchiectasis.

Y Miyazaki1, H Sakashita, T Tanaka, K Kamei, K Nishimura, Y Yoshizawa.   

Abstract

A 51-year-old female was admitted to our hospital because of fever, cough, and hemoptysis. A chest radiograph showed a partial collapse of the left upper division and infected bullae in the left upper lobe. Bronchoscopic examination showed thick mucous plugs in the left upper bronchus. The isolates of the plugs proved to be Schizophyllum commune. Neither accumulation of eosinophils nor Charcot-Leyden crystals were present in the plugs. Mild ectatic changes of the left upper bronchus had been observed 17 years previously. We describe the first case of mucoid impaction, which was independent of the immunological reactions, caused by S. commune in association with bronchiectasis.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10732837     DOI： 10.2169/internalmedicine.39.160

Source DB:  PubMed          Journal:  Intern Med        ISSN： 0918-2918            Impact factor:   1.271


  9 in total

Review 1.  First report of otitis externa caused by Schizophyllum commune and review of the literature.

Authors:  Tadeja Matos; Rok Tomazin; Saba Battelino
Journal:  Wien Klin Wochenschr       Date:  2016-01-22       Impact factor: 1.704

2.  Molecular characterization and in vitro antifungal susceptibility profile of Schizophyllum commune, an emerging basidiomycete in bronchopulmonary mycoses.

Authors:  Anuradha Chowdhary; Shallu Kathuria; Pradeep Kumar Singh; Kshitij Agarwal; Shailendra N Gaur; Pradip Roy; Harbans S Randhawa; Jacques F Meis
Journal:  Antimicrob Agents Chemother       Date:  2013-03-18       Impact factor: 5.191

3.  Nucleotide sequencing for diagnosis of sinusal infection by Schizophyllum commune, an uncommon pathogenic fungus.

Authors:  Olivier Baron; Sophie Cassaing; Josiane Percodani; Antoine Berry; Marie-Denise Linas; Richard Fabre; Elie Serrano; Jean François Magnaval
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

4.  Clinical significance of filamentous basidiomycetes illustrated by isolates of the novel opportunist Ceriporia lacerata from the human respiratory tract.

Authors:  Anuradha Chowdhary; Kshitij Agarwal; Shallu Kathuria; Pradeep Kumar Singh; P Roy; S N Gaur; G S de Hoog; Jacques F Meis
Journal:  J Clin Microbiol       Date:  2012-12-12       Impact factor: 5.948

5.  A favorable clinical effect of an expectorant in allergic bronchopulmonary mycosis caused by Schizophyllum commune.

Authors:  Haruki Kobayashi; Tetsuhiko Taira; Kazushige Wakuda; Toshiaki Takahashi; Masahiro Endo
Journal:  Respir Med Case Rep       Date:  2016-07-17

6.  Eosinophilic plasmacytic conjunctivitis concurrent with gingival fistula caused by Schizophyllum commune in a captive cheetah (Acinonyx jubatus).

Authors:  Madoka Yoshizawa; Shinpei Kawarai; Yoshiko Torii; Kaori Ota; Kiyoshi Tasaka; Kazuko Nishimura; Chieko Fujii; Nobuyuki Kanemaki
Journal:  Med Mycol Case Rep       Date:  2017-09-14

7.  First report on cutaneous infectious granuloma caused by Schizophyllum commune.

Authors:  Lidi Tian; Yunzhu Mu; Hao Zhang; Xiaocui Su; Chuan Yang; Xianzhu Shu; Defu Qing
Journal:  BMC Infect Dis       Date:  2018-06-26       Impact factor: 3.090

8.  Pulmonary Schizophyllum commune infection developing mucoid impaction of the bronchi.

Authors:  Takashi Ishiguro; Noboru Takayanagi; Daidou Tokunaga; Kazuyoshi Kurashima; Aya Matsushita; Keiji Harasawa; Koichiro Yoneda; Noriko Tsuchiya; Shozaburo Yamaguchi; Yousuke Miyahara; Ryozo Yano; Hiroo Saito; Mikio Ubukata; Tsutomu Yanagisawa; Yutaka Sugita; Yoshinori Kawabata
Journal:  Yale J Biol Med       Date:  2007-09

9.  Allergic Bronchopulmonary Mycosis Due to Schizophyllum commune Treated Effectively with Voriconazole.

Authors:  Takashi Ishiguro; Naho Kagiyama; Ayako Kojima; Masami Yamada; Yasuo Nakamoto; Yotaro Takaku; Yoshihiko Shimizu; Kazuyoshi Kurashima; Noboru Takayanagi
Journal:  Intern Med       Date:  2018-03-30       Impact factor: 1.271
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.